1. Home
  2. BCBP vs MDWD Comparison

BCBP vs MDWD Comparison

Compare BCBP & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCB Bancorp Inc. (NJ)

BCBP

BCB Bancorp Inc. (NJ)

HOLD

Current Price

$8.21

Market Cap

139.1M

Sector

Finance

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.78

Market Cap

224.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCBP
MDWD
Founded
2000
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Savings Institutions
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.1M
224.6M
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
BCBP
MDWD
Price
$8.21
$16.78
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$9.00
$36.00
AVG Volume (30 Days)
71.0K
67.6K
Earning Date
04-21-2026
03-05-2026
Dividend Yield
3.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$85.26
$57.63
Revenue Next Year
$6.14
$26.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.31
$14.14
52 Week High
$10.38
$22.51

Technical Indicators

Market Signals
Indicator
BCBP
MDWD
Relative Strength Index (RSI) 52.69 43.75
Support Level $7.84 $16.68
Resistance Level $8.66 $18.58
Average True Range (ATR) 0.21 0.59
MACD -0.00 -0.02
Stochastic Oscillator 62.50 27.29

Price Performance

Historical Comparison
BCBP
MDWD

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: